Evaluation of in vivo responses of sorafenib therapy in a preclinical mouse model of PTEN-deficient of prostate cancer

BACKGROUND: Despite recent advances in the treatment for advanced prostate cancer, outcomes remain poor. This lack of efficacy has prompted the development of alternative treatment strategies. In the present study we investigate the effects of the multikinase inhibitor sorafenib in a genetically eng...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Yutaka, De Velasco, Marco A, Kura, Yurie, Nozawa, Masahiro, Hatanaka, Yuji, Oki, Takashi, Ozeki, Takayuki, Shimizu, Nobutaka, Minami, Takafumi, Yoshimura, Kazuhiro, Yoshikawa, Kazuhiro, Nishio, Kazuto, Uemura, Hirotsugu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438623/
https://www.ncbi.nlm.nih.gov/pubmed/25953027
http://dx.doi.org/10.1186/s12967-015-0509-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438623/
https://www.ncbi.nlm.nih.gov/pubmed/25953027
http://dx.doi.org/10.1186/s12967-015-0509-x

Ejemplares similares